Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Innovative Healthcare Ishares Evolved ETF (IEIH)

US Innovative Healthcare Ishares Evolved ETF (IEIH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 41,710,500
  • Shares Outstanding, K 1,150
  • 60-Month Beta 0.71
Trade IEIH with:
  • Price/Earnings ttm 29.38
  • Annual Dividend & Yield 0.95 (2.61%)
  • Most Recent Dividend 0.086 on 06/10/21
  • Management Fee 0.18%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.91 +1.07%
on 09/17/21
37.65 -3.60%
on 08/24/21
-1.11 (-2.96%)
since 08/17/21
3-Month
34.06 +6.56%
on 06/18/21
37.65 -3.60%
on 08/24/21
+1.84 (+5.33%)
since 06/17/21
52-Week
28.55 +27.13%
on 10/30/20
37.65 -3.60%
on 08/24/21
+5.86 (+19.24%)
since 09/17/20

Most Recent Stories

More News
Pharma & Healthcare ETFs at a One-Year High: Here's Why

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.

JNJ : 164.75 (-0.28%)
PFE : 43.89 (-1.30%)
MRNA : 430.05 (-2.41%)
PJP : 78.92 (-0.01%)
IHE : 186.37 (-0.38%)
PPH : 73.22 (-0.66%)
FXH : 125.51 (+0.33%)
IEIH : 36.30 (+0.01%)
Time for Pharma and Healthcare ETFs?

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

MRNA : 430.05 (-2.41%)
IYH : 288.06 (+0.13%)
BBH : 217.91 (+0.53%)
FXH : 125.51 (+0.33%)
IEIH : 36.30 (+0.01%)
2 Sector ETFs Hovering Around All-Time Highs

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

NETL : 30.64 (-1.22%)
IYH : 288.06 (+0.13%)
BBH : 217.91 (+0.53%)
FXH : 125.51 (+0.33%)
RWR : 109.06 (-1.36%)
REZ : 88.13 (-1.55%)
NURE : 36.07 (-1.31%)
IEIH : 36.30 (+0.01%)
JNJ Beats on Q2 Earnings, Ups View: ETFs to Buy

The company recorded 164 million in COVID-19 vaccine sales in the second quarter, up 64% from the first, and aims to fetch $2.5 billion in sales by the end of the year.

JNJ : 164.75 (-0.28%)
XLV : 133.00 (+0.10%)
IYH : 288.06 (+0.13%)
VHT : 258.79 (+0.34%)
IHE : 186.37 (-0.38%)
IEIH : 36.30 (+0.01%)
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results

Johnson & Johnson (JNJ) continued its long streak of earnings beat and outpaced revenue estimates. However, the company tightened its full-year guidance.

JNJ : 164.75 (-0.28%)
XLV : 133.00 (+0.10%)
VHT : 258.79 (+0.34%)
IYH : 288.06 (+0.13%)
IHE : 186.37 (-0.38%)
IEIH : 36.30 (+0.01%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 164.75 (-0.28%)
XLV : 133.00 (+0.10%)
IYH : 288.06 (+0.13%)
IHE : 186.37 (-0.38%)
FTXH : 25.47 (-0.46%)
IEIH : 36.30 (+0.01%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 43.89 (-1.30%)
MRNA : 430.05 (-2.41%)
IHE : 186.37 (-0.38%)
FDL : 33.29 (-0.69%)
FTXH : 25.47 (-0.46%)
IEIH : 36.30 (+0.01%)
BNTX : 359.18 (-3.61%)
ETFs to Tap Amgen's Drive for Cancer Deal

Amgen (AMGN) has agreed to buy Five Prime Therapeutics (FPRX) for $1.9 billion.

BMY : 61.31 (+0.13%)
AMGN : 219.38 (+0.93%)
IBB : 173.61 (+0.64%)
FPRX : 38.00 (+0.03%)
BBH : 217.91 (+0.53%)
PJP : 78.92 (-0.01%)
IEIH : 36.30 (+0.01%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 164.75 (-0.28%)
XLV : 133.00 (+0.10%)
IYH : 288.06 (+0.13%)
IHE : 186.37 (-0.38%)
FTXH : 25.47 (-0.46%)
IEIH : 36.30 (+0.01%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 164.75 (-0.28%)
PFE : 43.89 (-1.30%)
MRNA : 430.05 (-2.41%)
XLV : 133.00 (+0.10%)
VHT : 258.79 (+0.34%)
IYH : 288.06 (+0.13%)
IHE : 186.37 (-0.38%)
IEIH : 36.30 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Evolved U.S. Innovative Healthcare ETF seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

See More

Key Turning Points

3rd Resistance Point 36.81
2nd Resistance Point 36.55
1st Resistance Point 36.42
Last Price 36.30
1st Support Level 36.04
2nd Support Level 35.78
3rd Support Level 35.65

See More

52-Week High 37.65
Last Price 36.30
Fibonacci 61.8% 34.17
Fibonacci 50% 33.10
Fibonacci 38.2% 32.03
52-Week Low 28.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar